UNLEASHING THE THERAPEUTIC POTENTIAL OF MRGPRs
Employees: 11-50
Total raised: $237.5M
Founded date: 2017
Investors 7
Funding Rounds 3
| Date | Series | Amount | Investors |
| 28.11.2022 | Series C | $120M | - |
| 12.10.2020 | Series B | $77.5M | - |
| 10.05.2018 | Series A | $40M | - |
Mentions in press and media 14
| Date | Title | Description | Source |
| 17.11.2023 | Simulocity Announces New Virtual Conference Center for Escie... | ORLANDO, FLORIDA, UNITED STATES, November 17, 2023 /EINPresswire.com/ -- Simulocity, a leading provi... | einpresswi... |
| 28.11.2022 | Escient Pharmaceuticals Announces $120 Million Series C Fina... | SAN DIEGO–(BUSINESS WIRE)–Escient Pharmaceuticals, a clinical-stage company advancing novel small mo... | avego.com/... |
| 28.11.2022 | Escient Pharmaceuticals acquires $120M of Series C Funding t... | - | connect.or... |
| 12.10.2020 | Escient Raises $77.5M Series B | Photo Courtesy of Escient Pharmaceuticals. San Diego biotech Escient Pharmaceuticals reeled in $77.5... | sdbj.com/n... |
| 14.09.2020 | Escient Pharmaceuticals has raised a $75.5 Million Series B ... | - | connect.or... |
| 14.09.2020 | Escient Pharmaceuticals Finds $77.5M In Series B | San Diego-based Escient Pharmaceuticals, which is developing treatments for mast cell-related diseas... | socaltech.... |
| 14.09.2020 | Escient Pharmaceuticals Raises $77.5 Million Series B Round ... | - | 5amventure... |
| 10.05.2018 | Escient Pharmaceutials Closes $40m in Series A Funding | Escient Pharmaceutials, a San Diego, CA-based biotech company, closed $40m in Series A funding. Bac... | finsmes.co... |
| 09.05.2018 | Biopharma startup Escient Pharmaceuticals launches with $40 ... | Marcus Boehm, the former CTO of Receptos, wasn’t supposed to start another company. He was going to ... | techstartu... |
| 09.05.2018 | Escient Pharmaceuticals Finds $40M | San Diego-based Escient Pharmaceuticals announced Wednesday morning that it has raised $40M in a Ser... | socaltech.... |
Show more